Product
APIs with DMF / COS or European Registered Drug Dossiers are suitably indicated in brackets. [Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement. The liability of any sale into such protected markets is at buyer’s risk.
Bulk APIs
| Regular APIs | |
| Dexketoprofen Trometamol (EU GMP), USDMF Filed | Levofloxacin Hemihydrate (EU GMP) |
| Homatropine Methylbromide (EU GMP), (USFDA) | Homatropine Hydrobromide (EU GMP) |
| Celecoxib (EU GMP), USDMF Filed | Pregabalin (EU GMP) |
| Diethyl Carbamazine Citrate EU GMP, WHO(Geneva) GMP,USDMF Filed | Ketorolac Trometamol (EU GMP) |
| Clopidogrel Besylate (DMF) | Febuxostat (DMF) |
| Atropine Sulfate (EU GMP), CEP & USDMF Filed | Alpha Lipoic Acid (DMF) |
| Cycloserine | |
| Under Validation | |
| Clopidogrel Bisulphate (Form I & Form II) | Dex Rabeprazole |
| Nebivolol | Vildagliptin |
| Rebamipide | Loxoprofen Sodium |
| Rabeprazole Sodium | R-Alpha Lipoic Acid |
| Under Development | |
| Tiotropium Anhydrous | R-Formoterol |
| Scopolamine | Ipratropium Bromide |
| Canagliflozin | Dapagliflozin Propanediol |
| Ramelteon | Empagliflozin |
| Selexipag | Obidoxime Chloride |
Advanced Intermediates
| Cephalosporin and Carbapenam Intermediates | |
| Benzylforminidate Hydrocloride [60099-09-4]-Meropenem | 4-Nitrobenzyl Diazoacetoacetate [82551-63-1] for Impienem |
| Mono 4-Nitrobenzyl Malonate [77359-11-6] for Meropenem | Mg salt of MNBM [83972-01-4] for Meropenem |
| Ethyl (Z)-2-[20(tritylamino) thiazol-4-yl]-2-(trityloxyimino) acetate [69689-86-7] for Cefdinir | (z)-4-Bromo-2-methoxyimino-3-oxobutyric acid [79232-66-9] [Bromo Acid] for Cefpodoxime Proxetil etc. |
| (z)-4-Chloro-2methoxyimino-3-oxobutyric acid [111230-59-2] [Chloro Acid] for Cefpodoxime Proxetil etc. | Acetoxyethyl Bromide [40258-78-4] for Cefuroxime Axetil |
| 4-Nitrobenzyl Bromide [100-11-8] for Cefaclor | 4-Nitro Benzyl Alcohol [619-73-8] for Carbapenems |
| S-1, 3 Benzothiazol-2yl (2z)-(acetoxyimine) (2-amino-1, 3 thiazol-4-yl) ethanethioate – [104797-47-9] – Cefdinir | |
| Naftifine Hydrochloride | |
| Cinnamyl chloride (2687-12-9) | N-Methylnapthalene-1 -methylamine (14489-75-9) |
| Epalrestat | |
| Alpha Methyl cinnamaldehyde (1 01-39-3) | |
| Lorcaserin | |
| 2-Chloro-N-4- chlorophenylethyl) propane-I -amine hydrochloride [953789-37-2] | |
| Zopiclone | |
| 6-(5-Chloropyrid-2-yl)-5-hydroxy-7-oxo-5, 6-dihydropyrrolo [3, 4-b] pyrazine [43200-81-3] | |
| Eprosartan | |
| Diethyl 2-thienyl methyl malonate (26420-00-8) | |
| Lisnopril | |
| L-Proline Benzyl Ester Hydrochloride [16652-71-4] | |
| Tiotropium | |
| Scopine di (2-thienyl) glycolate (136310-64-0) | |
| Aripiprazole | |
| Chloro Methyl Laurate (61413-67-0) | |
| Edoxaban | |
| ILC (1S,4S,5S)-4-lodo-6-oxabicyclo[3.2.1]octane-7-one (123536-66-3) | BLC (1 S,4S,5S)-4-Bromo-6-oxabicyclo[3.2.1 ]octane-7-one (139893-81-5) |
| Other Intermediates | |
| 1-2-Ethoxyethyl)benzimidazolone [101953-61-1] – Intermediate for new Anti-inflamatory drug |
5-Chlorosalicylic amide |
| L-alanine benzyl ester para toluene sulphonate | 5-bromo-2-chlorobenzoic acid |
| 4-(Bromomethyl) Quinoline-2 (1 H)-one (BMQ) (4876-10-2) | 2-Cyano-4-Bromomethyl Biphenyl (BMC) (114772-54-2) |